Brookline Capital Downgrades POINT Biopharma Global to Hold From Buy, Cuts ... - MarketScreener

Retrieved on: 2023-12-21 18:57:28

Tags for this article:

Click the tags to see associated articles and topics

Brookline Capital Downgrades POINT Biopharma Global to Hold From Buy, Cuts ... - MarketScreener. View article details on hiswai:

Excerpt

POINT Biopharma Global has an average rating of hold and price targets ranging from $12.50 to $21.93, according to analysts polled by Capital IQ.

Article found on: www.marketscreener.com